Article
A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
Journal of biological response modifiers - 1 Feb 1990
Shau H, Isacescu V, Ibayashi Y, Tokuda Y, Golub S H, Fahey J L, Sarna G P
Abstract excerpt
Patients with metastatic solid tumors were treated with six escalating doses of weekly intralymphatically injected recombinant interleukin 2 (i.l. IL-2). Nine patients completed the treatment and were evaluated for immunologic features of their peripheral blood lymphocytes (PBLs). The patients' P...
Topics
- Antigens, Differentiation
- Cytotoxicity Tests, Immunologic
- Humans
- Injections, Intralymphatic
- Interleukin-2
- Killer Cells, Lymphokine-Activated
- Killer Cells, Natural
- Lymphocytes
- Phenotype
- Pilot Projects
- Recombinant Proteins
